诺泰生物
(688076)
| 流通市值：107.03亿 | | | 总市值：107.03亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 561,512,124.49 | 555,215,624.54 | 544,179,868.29 | 749,082,430.38 |
| 应收票据及应收账款 | 559,359,774.58 | 489,135,468.67 | 335,941,092.25 | 297,256,634.78 |
| 其中：应收票据 | 1,863,007.91 | 1,295,220.1 | 2,189,121.67 | 1,061,378.4 |
| 应收账款 | 557,496,766.67 | 487,840,248.57 | 333,751,970.58 | 296,195,256.38 |
| 应收款项融资 | 1,595,761.65 | 1,300,000 | 96,000 | - |
| 预付款项 | 57,832,214.59 | 33,714,715.93 | 35,084,901.25 | 24,711,133.57 |
| 其他应收款合计 | 4,633,388.44 | 3,133,266.77 | 2,551,920.9 | 3,272,064.61 |
| 存货 | 521,105,440.8 | 436,045,081.46 | 394,493,365.54 | 377,174,248.78 |
| 其他流动资产 | 25,268,064.41 | 18,301,206.91 | 35,896,746.36 | 43,270,671.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,831,306,768.96 | 1,721,845,364.28 | 1,548,243,894.59 | 1,494,767,183.42 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 45,388,000 | 45,388,000 | 45,388,000 | 45,388,000 |
| 其他非流动金融资产 | 159,908,647.01 | 108,975,504.35 | 112,109,219.03 | 72,109,219.03 |
| 固定资产 | 1,332,929,513.58 | 1,324,368,445.52 | 1,222,215,096.82 | 1,196,072,853.22 |
| 在建工程 | 210,923,384.3 | 160,932,528.98 | 219,647,250.86 | 185,960,247.99 |
| 使用权资产 | 38,781,963.25 | 20,756,048.19 | 21,860,509.16 | 23,002,732.98 |
| 无形资产 | 105,542,076.45 | 108,167,477.81 | 110,063,883.88 | 112,099,856.96 |
| 开发支出 | 71,220,512.43 | 67,249,040.95 | 31,351,756.93 | 30,438,442.34 |
| 商誉 | 156,336,178.69 | 156,336,178.69 | 156,336,178.69 | 156,336,178.69 |
| 长期待摊费用 | 28,924,714.07 | 27,485,887.33 | 19,515,824.31 | 10,588,015.24 |
| 递延所得税资产 | 78,904,664.36 | 69,478,840.17 | 51,546,962.14 | 46,646,365.92 |
| 其他非流动资产 | 382,443,101.22 | 204,478,131.86 | 180,982,105.45 | 173,836,856.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,611,302,755.36 | 2,293,616,083.85 | 2,171,016,787.27 | 2,052,478,769.02 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,442,609,524.32 | 4,015,461,448.13 | 3,719,260,681.86 | 3,547,245,952.44 |
| 流动负债: | | | | |
| 短期借款 | 987,828,099.87 | 817,602,638.77 | 681,650,535.88 | 546,018,526.38 |
| 交易性金融负债 | 6,255.44 | - | - | - |
| 应付票据及应付账款 | 256,592,141.72 | 233,575,420.64 | 242,312,629.98 | 300,574,879.24 |
| 其中：应付票据 | 71,459,425.15 | 72,247,061.5 | 89,934,274.38 | 113,616,317.31 |
| 应付账款 | 185,132,716.57 | 161,328,359.14 | 152,378,355.6 | 186,958,561.93 |
| 合同负债 | 35,888,854.86 | 36,710,015.86 | 13,318,135.21 | 8,386,843.72 |
| 应付职工薪酬 | 46,833,705.47 | 38,516,988.76 | 27,887,406.92 | 51,188,841.33 |
| 应交税费 | 27,249,327.56 | 28,761,299.06 | 23,170,970.32 | 16,169,597.98 |
| 其他应付款合计 | 9,673,280.47 | 30,773,828.54 | 6,547,149.38 | 4,382,479.65 |
| 一年内到期的非流动负债 | 70,068,258.61 | 65,859,227.82 | 65,568,368.39 | 45,373,389.05 |
| 其他流动负债 | 2,551,125.96 | 1,833,569.91 | 3,142,932.74 | 1,240,654.58 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,436,691,049.96 | 1,253,632,989.36 | 1,063,598,128.82 | 973,335,211.93 |
| 非流动负债: | | | | |
| 长期借款 | 84,964,175.27 | - | - | - |
| 应付债券 | 160,594,856.45 | 248,859,577.63 | 292,449,039.83 | 286,491,719.75 |
| 租赁负债 | 31,496,318.51 | 15,976,722.5 | 16,024,472.77 | 17,182,874.99 |
| 长期应付款 | 52,746,800 | 39,306,800 | 39,306,800 | 39,306,800 |
| 递延收益 | 28,092,363.18 | 27,732,701.65 | 29,596,762.99 | 31,460,824.34 |
| 递延所得税负债 | 8,982,345.07 | 9,384,367.01 | 9,931,296.55 | 10,164,846.68 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 366,876,858.48 | 341,260,168.79 | 387,308,372.14 | 384,607,065.76 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,803,567,908.44 | 1,594,893,158.15 | 1,450,906,500.96 | 1,357,942,277.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 219,779,860 | 214,934,292 | 213,183,800 | 213,183,800 |
| 其他权益工具 | 69,837,336.07 | 116,379,829.76 | 140,869,582.43 | 140,869,582.43 |
| 资本公积 | 1,608,398,122.03 | 1,445,805,312.78 | 1,354,716,339.34 | 1,341,485,490.9 |
| 其他综合收益 | -24,745,200 | -24,745,200 | -24,745,200 | -24,745,200 |
| 专项储备 | 5,039,497.28 | 4,714,278.65 | 4,337,116.29 | 4,101,289.44 |
| 盈余公积 | 30,765,221.13 | 30,765,221.13 | 30,765,221.13 | 30,765,221.13 |
| 未分配利润 | 707,603,706.52 | 606,496,157.51 | 530,934,971.19 | 464,608,154.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,616,678,543.03 | 2,394,349,891.83 | 2,250,061,830.38 | 2,170,268,338.07 |
| 少数股东权益 | 22,363,072.85 | 26,218,398.15 | 18,292,350.52 | 19,035,336.68 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,639,041,615.88 | 2,420,568,289.98 | 2,268,354,180.9 | 2,189,303,674.75 |
| 负债和股东权益合计 | 4,442,609,524.32 | 4,015,461,448.13 | 3,719,260,681.86 | 3,547,245,952.44 |
| 公告日期 | 2024-10-23 | 2024-08-23 | 2024-04-23 | 2024-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |